Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LEFLUNOMIDE
- Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement
- Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement
- The Effect of Cilostazol on Rheumatoid Arthritis Patients
- The Clinical Efficacy of Immunomodulators in RA Patients
- Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial
- Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
- Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
- Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients
- Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease
- Leflunomide in Patients With PTEN-null Advanced Solid Malignancies
- Leflunomide for Musculoskeletal GVHD After Allogeneic Stem Cell Transplant
- The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis
- Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus in Treatment of BK Virus Infection in Kidney Transplantation Recipient
- Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy
- Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
- Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative Disorders
- Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma
- Leflunomide in Mild COVID-19 Patients
- Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis
- Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease
- Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
- Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma
- Psoriatic Oligoarthritis Intervention With Symptomatic thErapy
- Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial
- Reconstitution of CD4+CD25highCD127low/-Tcell
- Leflunomide Treatment for IgG4-RD
- Leflunomide in Previously Treated Metastatic Triple Negative Cancers
- Treatment With Leflunomide in Patients With Polymyalgia Rheumatica
- Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis
- Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis
- Takayasu Arteritis Clinical Trial in China
- Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis
- Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy
- A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs
- Leflunomide for Maintenance of Remission in IgG4 Related Disease
- Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis
- The Research of Standard Diagnosis and Treatment for HSPN in Children
- Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
- IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
- A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)
- Belimumab in Idiopathic Inflammatory Myositis
- 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection
- Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis
- To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis
- Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
- Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Sub-Study: Analysis of JCV Antibody Index in MS Patients Treated With Teriflunomide - SWITCH-JCV
- A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis
- Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients
- A Clinical Study of Xin'an Medicine in the Treatment of Bi Syndrome
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)
- Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis
- The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
- Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study
- A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action
- An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria
- Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood
- Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research
- Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
- A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
- Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis
- A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
- Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.
- Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
- Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain
- Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study
- A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
- To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions
- Leflunomide 20 mg Tablets Under Fasting Conditions
- Leflunomide 20 mg Tablets, Non-Fasting
- Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid
- BK Viremia After Renal Transplantation
- A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis
- Bioavailability Study of Leflunomide Tablets Under Fed Conditions
- Bioavailability Study of Leflunomide Tablets Under Fasting Conditions
- Leflunomide in Systemic Lupus Erythematosus
- Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis
- Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis
- Leflunomide + Methotrexate in Rheumatoid Arthritis
- Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis
- A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
- Objective Study in Rheumatoid Arthritis
- A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis
- Leflunomide in Rheumatoid Arthritis
- Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone
- New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis
- D2E7-Early AS
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
- Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients
- Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer
- Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse
- SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
- Leflunomide to Treat Uveitis
Clinical trials list
click for details